Treatment of gout in a renal transplant patient leading to severe thrombocytopenia.

Abstract

WHAT IS KNOWN AND OBJECTIVE Allopurinol (AP) inhibits the xanthine oxidase, which may indirectly lead to myelotoxicity when used in combination with azathioprine (AZA). CASE SUMMARY A 79-year-old female developed symptomatic thrombocytopenia after combination therapy with AZA (75 mg/day) and AP (100 mg/day) - after AP had been stopped. Concentrations of… (More)
DOI: 10.1111/jcpt.12190

Topics

Cite this paper

@article{Weiler2014TreatmentOG, title={Treatment of gout in a renal transplant patient leading to severe thrombocytopenia.}, author={Stefan Weiler and Nuria Aellig and Ivan Fauch{\`e}re and Alexander Jetter and Natascha Corti}, journal={Journal of clinical pharmacy and therapeutics}, year={2014}, volume={39 5}, pages={571-2} }